Roche drug tipped to remain key to treatment

Showing 1 posts of 1 posts found.

Avastin will remain gold standard for lung cancer to 2018

June 20, 2010
Decision Resources, NSCLC, Roche drug tipped to remain key to treatment, avastin

 Industry analysts Decision Resources believes that Roche’s Avastin plus chemotherapy agents will remain as the gold standard for the treatment …

Latest content